Interaction between the non-alcoholic fatty liver disease fibrosis score and vitamin D deficiency on left ventricular hypertrophy and impaired diastolic function in patients with type 2 diabetes mellitus
The present study aimed to evaluate the effect of Non-Alcoholic Fatty Liver Disease Fibrosis Score (NFS), vitamin D deficiency, and their interaction on the Left Ventricle (LV) structure and diastolic function in type 2 diabetes mellitus (T2DM) patients. A total of 595 T2DM patients were recruited a...
Saved in:
Published in | Diabetology and metabolic syndrome Vol. 17; no. 1; pp. 307 - 11 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
01.08.2025
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The present study aimed to evaluate the effect of Non-Alcoholic Fatty Liver Disease Fibrosis Score (NFS), vitamin D deficiency, and their interaction on the Left Ventricle (LV) structure and diastolic function in type 2 diabetes mellitus (T2DM) patients.
A total of 595 T2DM patients were recruited and stratified according to NFS grades (low, intermediate, and high) and the level of serum 25(OH)D (with and without vitamin D deficiency). Parameters of LV structure and diastolic dysfunction were measured by echocardiography. The association between NFS and LV structure and diastolic function was assessed using multivariable linear regression models stratified by vitamin D levels.
Left ventricular hypertrophy (LVH) was more prevalent in patients with high NFS compared to those with low and intermediate NFS (41.0 vs 14.0% and 9.0%, P < 0.001). The average E/e' was higher in patients with intermediate and high NFS, as compared to those with low NFS. Within the high NFS group, patients with vitamin D deficiency exhibited significantly higher left ventricular mass index (LVMI) and average E/e' compared to those without vitamin D deficiency. An interaction between vitamin D and NFS groups was found on both LVMI (P for interaction = 0.008) and average E/e' (P for interaction = 0.001).
NFS and vitamin D deficiency are associated with an increased risk of LVH and impaired diastolic function in patients with T2DM. Notably, the impact of vitamin D deficiency on these parameters is more pronounced in individuals with a high NFS score. |
---|---|
AbstractList | The present study aimed to evaluate the effect of Non-Alcoholic Fatty Liver Disease Fibrosis Score (NFS), vitamin D deficiency, and their interaction on the Left Ventricle (LV) structure and diastolic function in type 2 diabetes mellitus (T2DM) patients.AIMSThe present study aimed to evaluate the effect of Non-Alcoholic Fatty Liver Disease Fibrosis Score (NFS), vitamin D deficiency, and their interaction on the Left Ventricle (LV) structure and diastolic function in type 2 diabetes mellitus (T2DM) patients.A total of 595 T2DM patients were recruited and stratified according to NFS grades (low, intermediate, and high) and the level of serum 25(OH)D (with and without vitamin D deficiency). Parameters of LV structure and diastolic dysfunction were measured by echocardiography. The association between NFS and LV structure and diastolic function was assessed using multivariable linear regression models stratified by vitamin D levels.METHODSA total of 595 T2DM patients were recruited and stratified according to NFS grades (low, intermediate, and high) and the level of serum 25(OH)D (with and without vitamin D deficiency). Parameters of LV structure and diastolic dysfunction were measured by echocardiography. The association between NFS and LV structure and diastolic function was assessed using multivariable linear regression models stratified by vitamin D levels.Left ventricular hypertrophy (LVH) was more prevalent in patients with high NFS compared to those with low and intermediate NFS (41.0 vs 14.0% and 9.0%, P < 0.001). The average E/e' was higher in patients with intermediate and high NFS, as compared to those with low NFS. Within the high NFS group, patients with vitamin D deficiency exhibited significantly higher left ventricular mass index (LVMI) and average E/e' compared to those without vitamin D deficiency. An interaction between vitamin D and NFS groups was found on both LVMI (P for interaction = 0.008) and average E/e' (P for interaction = 0.001).RESULTSLeft ventricular hypertrophy (LVH) was more prevalent in patients with high NFS compared to those with low and intermediate NFS (41.0 vs 14.0% and 9.0%, P < 0.001). The average E/e' was higher in patients with intermediate and high NFS, as compared to those with low NFS. Within the high NFS group, patients with vitamin D deficiency exhibited significantly higher left ventricular mass index (LVMI) and average E/e' compared to those without vitamin D deficiency. An interaction between vitamin D and NFS groups was found on both LVMI (P for interaction = 0.008) and average E/e' (P for interaction = 0.001).NFS and vitamin D deficiency are associated with an increased risk of LVH and impaired diastolic function in patients with T2DM. Notably, the impact of vitamin D deficiency on these parameters is more pronounced in individuals with a high NFS score.CONCLUSIONSNFS and vitamin D deficiency are associated with an increased risk of LVH and impaired diastolic function in patients with T2DM. Notably, the impact of vitamin D deficiency on these parameters is more pronounced in individuals with a high NFS score. Aims The present study aimed to evaluate the effect of Non-Alcoholic Fatty Liver Disease Fibrosis Score (NFS), vitamin D deficiency, and their interaction on the Left Ventricle (LV) structure and diastolic function in type 2 diabetes mellitus (T2DM) patients. Methods A total of 595 T2DM patients were recruited and stratified according to NFS grades (low, intermediate, and high) and the level of serum 25(OH)D (with and without vitamin D deficiency). Parameters of LV structure and diastolic dysfunction were measured by echocardiography. The association between NFS and LV structure and diastolic function was assessed using multivariable linear regression models stratified by vitamin D levels. Results Left ventricular hypertrophy (LVH) was more prevalent in patients with high NFS compared to those with low and intermediate NFS (41.0 vs 14.0% and 9.0%, P < 0.001). The average E/e' was higher in patients with intermediate and high NFS, as compared to those with low NFS. Within the high NFS group, patients with vitamin D deficiency exhibited significantly higher left ventricular mass index (LVMI) and average E/e' compared to those without vitamin D deficiency. An interaction between vitamin D and NFS groups was found on both LVMI (P for interaction = 0.008) and average E/e' (P for interaction = 0.001). Conclusions NFS and vitamin D deficiency are associated with an increased risk of LVH and impaired diastolic function in patients with T2DM. Notably, the impact of vitamin D deficiency on these parameters is more pronounced in individuals with a high NFS score. Keywords: Non-alcoholic fatty liver disease fibrosis score, Vitamin D deficiency, Left ventricular hypertrophy, Left ventricular diastolic dysfunction, Type 2 diabetes mellitus The present study aimed to evaluate the effect of Non-Alcoholic Fatty Liver Disease Fibrosis Score (NFS), vitamin D deficiency, and their interaction on the Left Ventricle (LV) structure and diastolic function in type 2 diabetes mellitus (T2DM) patients. A total of 595 T2DM patients were recruited and stratified according to NFS grades (low, intermediate, and high) and the level of serum 25(OH)D (with and without vitamin D deficiency). Parameters of LV structure and diastolic dysfunction were measured by echocardiography. The association between NFS and LV structure and diastolic function was assessed using multivariable linear regression models stratified by vitamin D levels. Left ventricular hypertrophy (LVH) was more prevalent in patients with high NFS compared to those with low and intermediate NFS (41.0 vs 14.0% and 9.0%, P < 0.001). The average E/e' was higher in patients with intermediate and high NFS, as compared to those with low NFS. Within the high NFS group, patients with vitamin D deficiency exhibited significantly higher left ventricular mass index (LVMI) and average E/e' compared to those without vitamin D deficiency. An interaction between vitamin D and NFS groups was found on both LVMI (P for interaction = 0.008) and average E/e' (P for interaction = 0.001). NFS and vitamin D deficiency are associated with an increased risk of LVH and impaired diastolic function in patients with T2DM. Notably, the impact of vitamin D deficiency on these parameters is more pronounced in individuals with a high NFS score. Abstract Aims The present study aimed to evaluate the effect of Non-Alcoholic Fatty Liver Disease Fibrosis Score (NFS), vitamin D deficiency, and their interaction on the Left Ventricle (LV) structure and diastolic function in type 2 diabetes mellitus (T2DM) patients. Methods A total of 595 T2DM patients were recruited and stratified according to NFS grades (low, intermediate, and high) and the level of serum 25(OH)D (with and without vitamin D deficiency). Parameters of LV structure and diastolic dysfunction were measured by echocardiography. The association between NFS and LV structure and diastolic function was assessed using multivariable linear regression models stratified by vitamin D levels. Results Left ventricular hypertrophy (LVH) was more prevalent in patients with high NFS compared to those with low and intermediate NFS (41.0 vs 14.0% and 9.0%, P < 0.001). The average E/e′ was higher in patients with intermediate and high NFS, as compared to those with low NFS. Within the high NFS group, patients with vitamin D deficiency exhibited significantly higher left ventricular mass index (LVMI) and average E/e′ compared to those without vitamin D deficiency. An interaction between vitamin D and NFS groups was found on both LVMI (P for interaction = 0.008) and average E/e′ (P for interaction = 0.001). Conclusions NFS and vitamin D deficiency are associated with an increased risk of LVH and impaired diastolic function in patients with T2DM. Notably, the impact of vitamin D deficiency on these parameters is more pronounced in individuals with a high NFS score. The present study aimed to evaluate the effect of Non-Alcoholic Fatty Liver Disease Fibrosis Score (NFS), vitamin D deficiency, and their interaction on the Left Ventricle (LV) structure and diastolic function in type 2 diabetes mellitus (T2DM) patients. A total of 595 T2DM patients were recruited and stratified according to NFS grades (low, intermediate, and high) and the level of serum 25(OH)D (with and without vitamin D deficiency). Parameters of LV structure and diastolic dysfunction were measured by echocardiography. The association between NFS and LV structure and diastolic function was assessed using multivariable linear regression models stratified by vitamin D levels. Left ventricular hypertrophy (LVH) was more prevalent in patients with high NFS compared to those with low and intermediate NFS (41.0 vs 14.0% and 9.0%, P < 0.001). The average E/e' was higher in patients with intermediate and high NFS, as compared to those with low NFS. Within the high NFS group, patients with vitamin D deficiency exhibited significantly higher left ventricular mass index (LVMI) and average E/e' compared to those without vitamin D deficiency. An interaction between vitamin D and NFS groups was found on both LVMI (P for interaction = 0.008) and average E/e' (P for interaction = 0.001). NFS and vitamin D deficiency are associated with an increased risk of LVH and impaired diastolic function in patients with T2DM. Notably, the impact of vitamin D deficiency on these parameters is more pronounced in individuals with a high NFS score. AimsThe present study aimed to evaluate the effect of Non-Alcoholic Fatty Liver Disease Fibrosis Score (NFS), vitamin D deficiency, and their interaction on the Left Ventricle (LV) structure and diastolic function in type 2 diabetes mellitus (T2DM) patients.MethodsA total of 595 T2DM patients were recruited and stratified according to NFS grades (low, intermediate, and high) and the level of serum 25(OH)D (with and without vitamin D deficiency). Parameters of LV structure and diastolic dysfunction were measured by echocardiography. The association between NFS and LV structure and diastolic function was assessed using multivariable linear regression models stratified by vitamin D levels.ResultsLeft ventricular hypertrophy (LVH) was more prevalent in patients with high NFS compared to those with low and intermediate NFS (41.0 vs 14.0% and 9.0%, P < 0.001). The average E/e′ was higher in patients with intermediate and high NFS, as compared to those with low NFS. Within the high NFS group, patients with vitamin D deficiency exhibited significantly higher left ventricular mass index (LVMI) and average E/e′ compared to those without vitamin D deficiency. An interaction between vitamin D and NFS groups was found on both LVMI (P for interaction = 0.008) and average E/e′ (P for interaction = 0.001).ConclusionsNFS and vitamin D deficiency are associated with an increased risk of LVH and impaired diastolic function in patients with T2DM. Notably, the impact of vitamin D deficiency on these parameters is more pronounced in individuals with a high NFS score. |
ArticleNumber | 307 |
Audience | Academic |
Author | Wu, Min Huang, Jia-Yi Li, Shi-Ming Wang, Run Chen, Cong Guo, Ran Liu, Ming-Ya Li, Yun-Ming Yiu, Kai-Hang |
Author_xml | – sequence: 1 givenname: Yun-Ming surname: Li fullname: Li, Yun-Ming – sequence: 2 givenname: Jia-Yi surname: Huang fullname: Huang, Jia-Yi – sequence: 3 givenname: Ran surname: Guo fullname: Guo, Ran – sequence: 4 givenname: Shi-Ming surname: Li fullname: Li, Shi-Ming – sequence: 5 givenname: Cong surname: Chen fullname: Chen, Cong – sequence: 6 givenname: Min surname: Wu fullname: Wu, Min – sequence: 7 givenname: Run surname: Wang fullname: Wang, Run – sequence: 8 givenname: Ming-Ya surname: Liu fullname: Liu, Ming-Ya – sequence: 9 givenname: Kai-Hang surname: Yiu fullname: Yiu, Kai-Hang |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40751154$$D View this record in MEDLINE/PubMed |
BookMark | eNptks1u1DAUhSNURH_gBVggS0iITYodx0m8rMrfSJXYwNpy7OvGo8QebGeqeUZeCmdSSouQF7GuvnvOvfE5L06cd1AUrwm-JKRrPkRCMe9KXLESkw53JX1WnJGWdSXjvDl5dD8tzmPcYty0rK1fFKc1bhkhrD4rfm1cgiBVst6hHtIdgENpAJS9SjkqP_jRKmRkSgc02j0EpG0EGQEZ2wcfbURR-QBIOo32NsnJOvQRaTBWWXDqgLLwCCahPbgUrJpHGdBw2EFIwe-Gw7HRTjtpA-gsLmNaLWe3TpX1djJlrRTRnU0DSrkZVQuaB4aIJhhHm-b4snhu5Bjh1f33ovjx-dP366_lzbcvm-urm1LlvWlJjWx42zaMdLVuG6kV0ZUymhjeKeAVZxhLneuVUn2jqtYo1XKuOsUY74DSi2Kz6movt2IX7CTDQXhpxbHgw62QIVk1gshGFYemlprrGhvet7ShncE9gcqYXmet96vWLvifM8QkJhtVXkg68HMUtKKsrWpMFtu3_6BbPweXN12oFi9pwH-pW5n9rTM-5eddRMVVx3JO8t5Npi7_Q-WjYbIqx8zYXH_S8O5RwwByTEP047y8UHwKvrmfcu4n0A-_50_kMlCtgMrpiQHMA0KwWHIt1lyLnGtxzLWg9DfxHey9 |
Cites_doi | 10.2337/diacare.27.8.1879 10.1007/s11883-017-0637-2 10.1177/1479164113491125 10.1007/s11739-022-02966-2 10.1038/nrendo.2017.151 10.1002/hep.24737 10.1016/j.jhep.2024.04.031 10.1371/journal.pone.0157517 10.2337/diacare.24.1.5 10.1016/j.jacc.2009.07.054 10.1080/08037051.2018.1527177 10.1038/ajg.2016.51 10.1002/hep.26390 10.1007/s00125-005-1896-y 10.1093/ehjopen/oead108 10.1016/j.jdiacomp.2014.01.003 10.1016/j.atherosclerosis.2015.05.002 10.1016/j.jhep.2019.06.021 10.3390/nu11040794 10.1016/j.jacc.2017.05.031 10.1016/j.echo.2016.01.011 10.4093/dmj.2019.0001 10.3389/fendo.2022.992666 10.1016/j.jhep.2017.11.023 10.1172/JCI0215219 10.1161/CIRCULATIONAHA.110.955542 10.1002/hep.21496 10.1038/bonekey.2013.214 10.1016/j.atherosclerosis.2020.03.010 10.1007/s11892-021-01383-7 10.1016/j.dsx.2018.03.011 10.1161/01.CIR.55.4.613 10.1016/j.jhep.2018.10.033 10.1093/eurheartj/ehab809 10.3389/fendo.2020.564738 10.1002/hep.28431 10.1111/jgh.15387 10.2147/DMSO.S299422 10.1016/j.echo.2014.10.003 10.1038/s41430-020-0558-y 10.1253/circj.CJ-12-0722 10.1111/joim.12007 10.2147/DMSO.S203700 10.1111/jdi.13430 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S 10.3390/nu13030830 10.1016/j.cgh.2018.12.031 10.1016/j.jhep.2016.05.013 10.1016/j.atherosclerosis.2018.03.027 10.1002/hep.26156 10.1371/journal.pone.0058808 |
ContentType | Journal Article |
Copyright | 2025. The Author(s). COPYRIGHT 2025 BioMed Central Ltd. 2025. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: 2025. The Author(s). – notice: COPYRIGHT 2025 BioMed Central Ltd. – notice: 2025. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | AAYXX CITATION NPM 3V. 7QP 7TS 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S PHGZM PHGZT PIMPY PKEHL PQEST PQQKQ PQUKI 7X8 DOA |
DOI | 10.1186/s13098-025-01808-3 |
DatabaseName | CrossRef PubMed ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts Physical Education Index Health & Medical Collection ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef PubMed Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Physical Education Index ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Central (New) ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals (DOAJ) url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1758-5996 |
EndPage | 11 |
ExternalDocumentID | oai_doaj_org_article_69729e64ad9d40f9b73638f0b1e2ffbd A850186516 40751154 10_1186_s13098_025_01808_3 |
Genre | Journal Article |
GeographicLocations | Canada China Shenzhen China |
GeographicLocations_xml | – name: Canada – name: Shenzhen China – name: China |
GrantInformation_xml | – fundername: the Sanming Project of Medicine in Shenzhen, China grantid: No. SZSM201911020 – fundername: High Level-Hospital Program, Health Commission of Guangdong Province, China grantid: No. HKUSZH201901001 – fundername: HKU-SZH Fund for Shenzhen Key Medical Discipline grantid: No. SZXK2020081 |
GroupedDBID | --- 0R~ 53G 5VS 7X7 8FI 8FJ AAFWJ AAJSJ AASML AAYXX ABDBF ABUWG ACGFO ACGFS ACPRK ACUHS ADBBV ADUKV AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AOIJS BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CITATION DIK E3Z EBD EBLON EBS ESX FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IEA IHR IHW ITC KQ8 M~E O5R O5S OK1 P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC RBZ RNS ROL RPM RSV SMD SOJ TUS U2A UKHRP NPM 3V. 7QP 7TS 7XB 8FK AZQEC DWQXO K9. M48 PKEHL PQEST PQUKI 7X8 PUEGO |
ID | FETCH-LOGICAL-c4073-3fa697765184d76adc1d2cfd1f98ce929500ad6ad2ccb6c27fcc799c8c5598e33 |
IEDL.DBID | 7X7 |
ISSN | 1758-5996 |
IngestDate | Wed Aug 27 01:20:50 EDT 2025 Sat Aug 02 17:30:47 EDT 2025 Wed Aug 06 19:28:27 EDT 2025 Wed Aug 06 19:14:40 EDT 2025 Tue Aug 05 03:51:26 EDT 2025 Tue Aug 05 02:11:47 EDT 2025 Wed Aug 06 16:36:42 EDT 2025 Thu Aug 07 06:14:17 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Vitamin D deficiency Type 2 diabetes mellitus Left ventricular diastolic dysfunction Non-alcoholic fatty liver disease fibrosis score Left ventricular hypertrophy |
Language | English |
License | 2025. The Author(s). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4073-3fa697765184d76adc1d2cfd1f98ce929500ad6ad2ccb6c27fcc799c8c5598e33 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://www.proquest.com/docview/3237013090?pq-origsite=%requestingapplication% |
PMID | 40751154 |
PQID | 3237013090 |
PQPubID | 54993 |
PageCount | 11 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_69729e64ad9d40f9b73638f0b1e2ffbd proquest_miscellaneous_3235724013 proquest_journals_3237013090 gale_infotracmisc_A850186516 gale_infotracacademiconefile_A850186516 gale_healthsolutions_A850186516 pubmed_primary_40751154 crossref_primary_10_1186_s13098_025_01808_3 |
PublicationCentury | 2000 |
PublicationDate | 2025-Aug-01 |
PublicationDateYYYYMMDD | 2025-08-01 |
PublicationDate_xml | – month: 08 year: 2025 text: 2025-Aug-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | Diabetology and metabolic syndrome |
PublicationTitleAlternate | Diabetol Metab Syndr |
PublicationYear | 2025 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | G Targher (1808_CR8) 2016; 65 Y Chen (1808_CR29) 2015; 241 Y Chen (1808_CR21) 2014; 28 1808_CR36 CL Roth (1808_CR40) 2012; 55 GA Nichols (1808_CR1) 2004; 27 HS Chun (1808_CR31) 2021; 36 D Kim (1808_CR30) 2013; 57 YC Li (1808_CR45) 2002; 110 SF Nagueh (1808_CR28) 2016; 29 A Zhou (1808_CR35) 2022; 43 GE Chung (1808_CR14) 2018; 272 Y Zheng (1808_CR5) 2018; 14 R Hidayat (1808_CR15) 2010; 42 ZM Younossi (1808_CR6) 2016; 64 Y-H Lee (1808_CR13) 2018; 68 H Darraj (1808_CR16) 2019; 12 K Hirose (1808_CR53) 2023; 3 1808_CR26 KG Alberti (1808_CR22) 1998; 15 A Sonaglioni (1808_CR52) 2022; 17 C Caussy (1808_CR10) 2021; 21 ACT Ng (1808_CR4) 2010; 122 ZM Younossi (1808_CR7) 2019; 71 B Li (1808_CR39) 2013; 8 SM Barbalho (1808_CR47) 2018; 12 K Amrein (1808_CR25) 2020; 74 Y Xiao (1808_CR17) 2020; 11 Q Chen (1808_CR32) 2020; 299 H Lee (1808_CR12) 2020; 44 O Kuloğlu (1808_CR19) 2013; 10 L Xiu (1808_CR20) 2021; 14 K Chin (1808_CR37) 2017; 19 JE Nelson (1808_CR41) 2016; 111 RB Devereux (1808_CR27) 1977; 55 A Dawson (1808_CR2) 2005; 48 MT Long (1808_CR33) 2016; 11 ZM Younossi (1808_CR9) 2019; 70 D Gao (1808_CR38) 2005; 2013 RM Kwok (1808_CR42) 2013; 58 S Warita (1808_CR50) 2012; 76 R Bouillon (1808_CR43) 2014; 3 P Angulo (1808_CR24) 2007; 45 1808_CR49 1808_CR48 B Williams (1808_CR23) 2018; 27 N Fan (1808_CR34) 2021; 12 1808_CR46 1808_CR11 1808_CR3 1808_CR51 P Ameri (1808_CR18) 2013; 273 I Portales-Castillo (1808_CR44) 2022; 13 |
References_xml | – volume: 27 start-page: 1879 year: 2004 ident: 1808_CR1 publication-title: Diab Care doi: 10.2337/diacare.27.8.1879 – volume: 19 start-page: 5 year: 2017 ident: 1808_CR37 publication-title: Curr Atheroscler Rep doi: 10.1007/s11883-017-0637-2 – volume: 10 start-page: 546 year: 2013 ident: 1808_CR19 publication-title: Diab Vasc Dis Res doi: 10.1177/1479164113491125 – volume: 17 start-page: 1425 issue: 5 year: 2022 ident: 1808_CR52 publication-title: Intern Emerg Med doi: 10.1007/s11739-022-02966-2 – volume: 14 start-page: 88 year: 2018 ident: 1808_CR5 publication-title: Nat Rev Endocrinol doi: 10.1038/nrendo.2017.151 – volume: 55 start-page: 1103 year: 2012 ident: 1808_CR40 publication-title: Hepatology doi: 10.1002/hep.24737 – ident: 1808_CR51 doi: 10.1016/j.jhep.2024.04.031 – volume: 11 start-page: e0157517 year: 2016 ident: 1808_CR33 publication-title: PLoS ONE doi: 10.1371/journal.pone.0157517 – ident: 1808_CR3 doi: 10.2337/diacare.24.1.5 – volume: 42 start-page: 123 year: 2010 ident: 1808_CR15 publication-title: Acta Med Indones – ident: 1808_CR49 doi: 10.1016/j.jacc.2009.07.054 – volume: 27 start-page: 314 year: 2018 ident: 1808_CR23 publication-title: Blood Press doi: 10.1080/08037051.2018.1527177 – volume: 111 start-page: 852 year: 2016 ident: 1808_CR41 publication-title: Am J Gastroenterol doi: 10.1038/ajg.2016.51 – volume: 58 start-page: 1166 year: 2013 ident: 1808_CR42 publication-title: Hepatology doi: 10.1002/hep.26390 – volume: 48 start-page: 1971 year: 2005 ident: 1808_CR2 publication-title: Diabetologia doi: 10.1007/s00125-005-1896-y – volume: 3 start-page: oead108 issue: 6 year: 2023 ident: 1808_CR53 publication-title: Eur Heart J Open doi: 10.1093/ehjopen/oead108 – volume: 28 start-page: 286 year: 2014 ident: 1808_CR21 publication-title: J Diab Compl doi: 10.1016/j.jdiacomp.2014.01.003 – volume: 241 start-page: 145 year: 2015 ident: 1808_CR29 publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2015.05.002 – volume: 71 start-page: 793 year: 2019 ident: 1808_CR7 publication-title: J Hepatol doi: 10.1016/j.jhep.2019.06.021 – ident: 1808_CR46 doi: 10.3390/nu11040794 – ident: 1808_CR36 doi: 10.1016/j.jacc.2017.05.031 – volume: 29 start-page: 277 year: 2016 ident: 1808_CR28 publication-title: J Am Soc Echocardiogr doi: 10.1016/j.echo.2016.01.011 – volume: 44 start-page: 267 year: 2020 ident: 1808_CR12 publication-title: Diab Metab J doi: 10.4093/dmj.2019.0001 – volume: 13 start-page: 992666 year: 2022 ident: 1808_CR44 publication-title: Front Endocrinol doi: 10.3389/fendo.2022.992666 – volume: 68 start-page: 764 year: 2018 ident: 1808_CR13 publication-title: J Hepatol doi: 10.1016/j.jhep.2017.11.023 – volume: 110 start-page: 229 year: 2002 ident: 1808_CR45 publication-title: J Clin Investig doi: 10.1172/JCI0215219 – volume: 122 start-page: 2538 year: 2010 ident: 1808_CR4 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.110.955542 – volume: 45 start-page: 846 year: 2007 ident: 1808_CR24 publication-title: Hepatology doi: 10.1002/hep.21496 – volume: 3 start-page: 480 year: 2014 ident: 1808_CR43 publication-title: Bonekey Rep doi: 10.1038/bonekey.2013.214 – volume: 299 start-page: 45 year: 2020 ident: 1808_CR32 publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2020.03.010 – volume: 21 start-page: 15 year: 2021 ident: 1808_CR10 publication-title: Curr Diab Rep doi: 10.1007/s11892-021-01383-7 – volume: 12 start-page: 501 year: 2018 ident: 1808_CR47 publication-title: Diab Metab Syndr doi: 10.1016/j.dsx.2018.03.011 – volume: 55 start-page: 613 year: 1977 ident: 1808_CR27 publication-title: Circulation doi: 10.1161/01.CIR.55.4.613 – volume: 70 start-page: 531 year: 2019 ident: 1808_CR9 publication-title: J Hepatol doi: 10.1016/j.jhep.2018.10.033 – volume: 43 start-page: 1731 year: 2022 ident: 1808_CR35 publication-title: Eur Heart J doi: 10.1093/eurheartj/ehab809 – volume: 11 start-page: 564738 year: 2020 ident: 1808_CR17 publication-title: Front Endocrinol doi: 10.3389/fendo.2020.564738 – volume: 2013 start-page: 357 issue: 37 year: 2005 ident: 1808_CR38 publication-title: Int J Obes – volume: 64 start-page: 73 year: 2016 ident: 1808_CR6 publication-title: Hepatology doi: 10.1002/hep.28431 – volume: 36 start-page: 1703 year: 2021 ident: 1808_CR31 publication-title: J Gastroenterol Hepatol doi: 10.1111/jgh.15387 – volume: 14 start-page: 1823 year: 2021 ident: 1808_CR20 publication-title: Diab Metab Syndr Obes Targets Therapy doi: 10.2147/DMSO.S299422 – ident: 1808_CR26 doi: 10.1016/j.echo.2014.10.003 – volume: 74 start-page: 1498 year: 2020 ident: 1808_CR25 publication-title: Eur J Clin Nutr doi: 10.1038/s41430-020-0558-y – volume: 76 start-page: 2755 year: 2012 ident: 1808_CR50 publication-title: Circ J doi: 10.1253/circj.CJ-12-0722 – volume: 273 start-page: 253 year: 2013 ident: 1808_CR18 publication-title: J Intern Med doi: 10.1111/joim.12007 – volume: 12 start-page: 853 year: 2019 ident: 1808_CR16 publication-title: Diab Metab Syndr Obes Targets Therapy doi: 10.2147/DMSO.S203700 – volume: 12 start-page: 1035 year: 2021 ident: 1808_CR34 publication-title: J Diabetes Investig doi: 10.1111/jdi.13430 – volume: 15 start-page: 539 year: 1998 ident: 1808_CR22 publication-title: Diab Med doi: 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S – ident: 1808_CR48 doi: 10.3390/nu13030830 – ident: 1808_CR11 doi: 10.1016/j.cgh.2018.12.031 – volume: 65 start-page: 589 year: 2016 ident: 1808_CR8 publication-title: J Hepatol doi: 10.1016/j.jhep.2016.05.013 – volume: 272 start-page: 137 year: 2018 ident: 1808_CR14 publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2018.03.027 – volume: 57 start-page: 1357 year: 2013 ident: 1808_CR30 publication-title: Hepatology doi: 10.1002/hep.26156 – volume: 8 start-page: e58808 year: 2013 ident: 1808_CR39 publication-title: PLoS ONE doi: 10.1371/journal.pone.0058808 |
SSID | ssj0067574 |
Score | 2.361411 |
Snippet | The present study aimed to evaluate the effect of Non-Alcoholic Fatty Liver Disease Fibrosis Score (NFS), vitamin D deficiency, and their interaction on the... Aims The present study aimed to evaluate the effect of Non-Alcoholic Fatty Liver Disease Fibrosis Score (NFS), vitamin D deficiency, and their interaction on... AimsThe present study aimed to evaluate the effect of Non-Alcoholic Fatty Liver Disease Fibrosis Score (NFS), vitamin D deficiency, and their interaction on... Abstract Aims The present study aimed to evaluate the effect of Non-Alcoholic Fatty Liver Disease Fibrosis Score (NFS), vitamin D deficiency, and their... |
SourceID | doaj proquest gale pubmed crossref |
SourceType | Open Website Aggregation Database Index Database |
StartPage | 307 |
SubjectTerms | 25-Hydroxyvitamin D Alcoholics Alfacalcidol Antihypertensives Blood platelets Blood pressure Body mass index Calcifediol Canada Cholesterol Diabetes Diabetes mellitus (non-insulin dependent) Diet therapy Diseases Doppler effect Echocardiography Fatty liver Fibrosis Heart Heart enlargement Heart failure High density lipoprotein Hypertension Hypertrophy Left ventricular diastolic dysfunction Left ventricular hypertrophy Liver diseases Non-alcoholic fatty liver disease fibrosis score Regression analysis Structure-function relationships Type 2 diabetes Type 2 diabetes mellitus Ventricle Vitamin D Vitamin D deficiency Vitamin deficiency Womens health |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYlh9JLafp0k7RTKPRQTGzJLx3TRwiF9NRAbkIeSXQh2Q1rbyG_MX8qM5K9dNtDL70ZeyxbmtFoZjTzSYj3VWGVrjySk0O-SeW7Ou91QLqyqnDobVlzvfP59-bsovp2WV_-dtQX54QleOA0cMeNJvPPN5V12lVF0H2rSGRC0ZdehtA71r605s3OVNLBZAW31Vwi0zXHA2lqLiWTnKjWcURwZxmKaP1_6-Q_LM244pw-EY8nUxFO0i_uiwd--VQ8PJ82w5-JuxjNS4UJMOVbAdlzQB59btPRtwuEYMfxFq44_wKm7RgI5CSvhsUAA6NYgl06-LUY7fViCV_AeUaV4JJMoIavfBiBkyJjpNCu4Sd5rutxvSL-xBe5zpL0pqPGLVmS8ZO0WMa_ovYm4NYBOOILHPEFCXPEF64ZD3TcDM_FxenXH5_P8ulshhzJBVS5CpY40zY1eYiubazD0kkMrgy6Q082V10U1tF9idg3KNuA2GqNHTIivFfqhdij0fCvBKAL5LNoh5UuqlB2NhANyr7sgyd1LDPxcWaVuUkQHCa6Ll1jEmMNMdZExhqViU_MzS0lw2fHGyRUZhIq8y-hysRblgWTalG3SsCcdIx_SJ1uMvEhUrAaGInVdqpmoC4xoNYO5eEOJU1f3H08y5uZ1MdglFQtbynrIhPvto_5TU6JW_rVJtLUrWT3OBMvk5xuO00sqhln6fX_GIwD8UjGmcNZj4dib1xv_BFZYmP_Jk66e8A2NK4 priority: 102 providerName: Directory of Open Access Journals |
Title | Interaction between the non-alcoholic fatty liver disease fibrosis score and vitamin D deficiency on left ventricular hypertrophy and impaired diastolic function in patients with type 2 diabetes mellitus |
URI | https://www.ncbi.nlm.nih.gov/pubmed/40751154 https://www.proquest.com/docview/3237013090 https://www.proquest.com/docview/3235724013 https://doaj.org/article/69729e64ad9d40f9b73638f0b1e2ffbd |
Volume | 17 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3daxQxEA_agvgifrtazxEEH2TpbrJfeZJWW4vQImLh3kI2H3rQ3tXdvUL_Rv8pZ7LZk1Pw5Th2Z3Obm2Qyv8nML4y9KTItZOEMghzEJoVryrSV3uA3LTJrnM5Lqnc-PatOzovP83IeA259TKucbGIw1HZlKEa-L7ioaZdNZu-vfqZ0ahTtrsYjNG6zXaIuo1FdzzeAC33hupgKZZpqv6fHm5QOcCXaqiYVW4tR4Oz_1zL_5W-Gdef4PrsXHUY4GDX8gN1yy4fszmncEn_EfoWY3lieADHrCtCrA8T1qR4PwF0Y8HoYbuCCsjAgbsqAR6i86hc99MRlCXpp4Xox6MvFEj6CdcQtQYWZgA1fOD8ApUaGeKHu4Afi127oVqil8CBVW6L1tNi4Rn8y_CQumeGtsL1I39oDxX2B4r7AYYr7wiWxgg7r_jE7Pz769uEkjSc0pAaBoEiF1xU6kFWJONHWlbYmt9x4m3vZGIeeV5ll2uJ1bkxbGV57Y2opTWOIF94J8YTt4L_hnjEw1iNykdYUMit83miPMoa3eesdGmWesHeTqtTVSMShAoBpKjUqVqFiVVCsEgk7JG1uJIlEO1xYdd9VnJMKX51LVxXaSltkXra1QGvkszZ33PvWJuwVjQU1VqRuTIE6aIgFETtdJextkCBjMKCqdaxpwC4RrdaW5N6WJE5is317Gm8qGpFe_RnyCXu9uU1PUmLc0q3WQaasOYHkhD0dx-mm06iiktiWnv-_8RfsLg9zgrIa99jO0K3dS_S0hnYWptOM7R4enX35OgvxCvz8NM9_A6v5Lvo |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELaqIgEXxLuBQgcJxAFFTZynDwgVSrWl3Z5aaW_G8QNWapOyyYL6p_gj_ClmnGTRgsStt1Uy8TqZ8Xi-8TwYe5lGKhGp1QhyEJuktszCSjiNv1QSGW1VnFG-8_Qkn5yln2bZbIP9HHNhKKxy1IleUZtGk498N-FJQadsInp3-S2krlF0ujq20OjF4she_UDI1r493Ef-vuL84OPph0k4dBUINYKXJEycytHoyTPENqbIldGx4dqZ2IlSW7QWsihSBq9zratc88JpXQihS021zC05QFHl38CNNyKwV8xWAA9t7yIdE3PKfLel6ZYhNYylMlllmKxtfr5HwL87wV_2rd_nDu6yO4OBCnu9RN1jG7a-z25OhyP4B-yX9yH26RAwRHkBWpFQN3Wo-oa7cw1Odd0VnFPUBwyHQOAQmjftvIWWameCqg18n3fqYl7DPhhLtSwoERRw4HPrOqBQTO-fVAv4inh50S0alAr_IGV3orY2OLhC-9X_JW7RflY43lAutgXyMwP5mYHD6GeGC6pC2i3bh-zsWnj3iG3i17BbDLRxiJSE0amIUheXyiGN5lVcOYubAA_Ym5FV8rIv_CE9YCpz2TNWImOlZ6xMAvaeuLmipKLd_kKz-CIHHSBx6lzYPFVGmDRyoioS1H4uqmLLnatMwHZIFmSfAbtSPXKvpKqL-NJ5wF57ClI-HbJaDTkU-EpUxmuNcnuNEpWGXr89ypsclFYr_yyxgL1Y3aYnKRCvts3S02QFJ1AesMe9nK5eGlmUUXWnJ_8ffIfdmpxOj-Xx4cnRU3ab-_VBEZXbbLNbLO0ztPK66rlfWsA-X_da_g0CBmj5 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Interaction+between+the+non-alcoholic+fatty+liver+disease+fibrosis+score+and+vitamin+D+deficiency+on+left+ventricular+hypertrophy+and+impaired+diastolic+function+in+patients+with+type+2+diabetes+mellitus&rft.jtitle=Diabetology+and+metabolic+syndrome&rft.au=Li%2C+Yun-Ming&rft.au=Huang%2C+Jia-Yi&rft.au=Guo%2C+Ran&rft.au=Li%2C+Shi-Ming&rft.date=2025-08-01&rft.pub=BioMed+Central+Ltd&rft.issn=1758-5996&rft.eissn=1758-5996&rft.volume=17&rft.issue=1&rft_id=info:doi/10.1186%2Fs13098-025-01808-3&rft.externalDocID=A850186516 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1758-5996&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1758-5996&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1758-5996&client=summon |